Pricing Log in Create free account
Saturday 17 October 2026 Export LLY’s income statement to Excel — free account

Eli Lilly and Company

LLY Healthcare Drug Manufacturers General

Eli Lilly and Company’s revenue for fiscal 2025 (year ended December 2025) was $65.2 billion, up 44.7% from fiscal 2024. In the quarter to June 2026, revenue grew 47.7%, EPS grew 26.2%, free cash flow grew 458.1% and total debt rose 37.6%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for five.

1,257.03 5.42 +0.43%
Market cap
$1.18T
P/E
42.2×
Fwd P/E
33.1×
Dividend yield
0.53%
F-score
7/9
Altman Z
8.61
Beneish M
−1.91
Dividend safety
86/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Eli Lilly and Company (LLY) P/B ratio

Alert me on P/B ratio

As of 16 October 2026, Eli Lilly and Company (LLY) trades at a P/B ratio of 33.1×. Over the past ten years it has ranged from 4.5× (December 2016) to 65.7× (March 2024); the current reading is higher than 65% of that period. That is above the Drug Manufacturers General industry median of 5.0× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 36.3× (25.40%)
FY2024 48.7× (0.73%)
FY2023 49.1× 60.66%
FY2022 30.5× 11.62%
FY2021 27.4× 4.02%
FY2020 26.3× (41.97%)
FY2019 45.3× 315.87%
FY2018 10.9× 42.78%
FY2017 7.6× 36.17%
FY2016 5.6× (8.57%)

Quarterly newest first

Period P/B ratio Change
Jun 2026 31.6× 19.80%
Mar 2026 26.4× (27.43%)
Dec 2025 36.3× 26.66%
Sep 2025 28.7× (24.78%)
42 more quarters

Against its own ten years

Low 4.5× High 65.7×
Ten-year median 29.5×
Current reading's percentile 62

P/B ratio against peers

Company P/B ratio
ABBV AbbVie Inc. compare n/m
PFE Pfizer Inc. compare 2.0×
AZN AstraZeneca PLC compare 5.1×
NVS Novartis AG compare 6.8×
JNJ Johnson & Johnson compare 7.2×
MRK Merck & Co., Inc. compare 8.6×
GILD Gilead Sciences, Inc. compare 16.5×
AMGN Amgen Inc. compare 20.0×
LLY Eli Lilly and Company 33.1×
Drug Manufacturers General industry median 5.0×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on LLY